Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
25.3% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Swire Properties
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Mixed-use Projects In China And Hong Kong Will Transform Cities
Key Takeaways Expansion in major Chinese cities, strong ESG credentials, and premium tenant engagement drive revenue growth, high occupancy, and robust margins amid rising demand for sustainable spaces. Solid financial position and ongoing premium project launches enable further acquisitions, asset reinvestment, and long-term earnings and dividend growth.
View narrative
HK$23.06
FV
9.1% undervalued
intrinsic discount
11.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
6 days ago
author updated this narrative
2618
JD Logistics
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Automation And Global Logistics Expansion Will Reshape Supply Chains
Key Takeaways Emphasis on high-margin services, technology adoption, and international expansion drives revenue diversification and sustained margin improvement. Growth in third-party customers and favorable market trends support long-term earnings momentum and reduce reliance on the parent company.
View narrative
HK$17.55
FV
21.2% undervalued
intrinsic discount
10.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
6 days ago
author updated this narrative
XPO
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Automation And Regulatory Pressures Will Squeeze Operating Margins
Key Takeaways Rising automation, AI adoption, and new digital competitors threaten XPO's market share, efficiency, and ability to maintain pricing power. Sustainability mandates, labor shortages, and costly tech initiatives are likely to compress margins and impede future earnings growth.
View narrative
US$106.24
FV
26.8% overvalued
intrinsic discount
3.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
United Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Patent Expirations And Biosimilar Pressures Will Diminish Value
Key Takeaways Heavy dependence on a few core drugs heightens risk from patent expirations, increasing vulnerability to revenue declines and competition from generics. Significant investments in novel therapies face technical and regulatory uncertainties, with potential delays and high costs threatening profitability and future earnings.
View narrative
US$295.00
FV
3.5% overvalued
intrinsic discount
1.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
UWM Holdings
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
High Rates And Margin Compression Will Hinder Mortgage Growth
Key Takeaways Reliance on aggressive pricing and traditional broker channels risks margin erosion and limits growth amid rising alternative financing models. Elevated operational complexity and regulatory scrutiny may increase costs and threaten profitability as technology and servicing investments expand.
View narrative
US$4.50
FV
26.4% overvalued
intrinsic discount
7.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Bank Negara Indonesia (Persero)
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
Shift Towards Corporate And Consumer Loans Expected To Improve Future Prospects
Key Takeaways Strategic focus on corporate and consumer loans with digital and branch transformations is expected to improve revenue and net margins. Asset quality improvement and prudent provisioning efforts are likely to stabilize earnings and support sustainable profit growth.
View narrative
Rp5.16k
FV
13.7% undervalued
intrinsic discount
19.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
35
users have followed this narrative
6 days ago
author updated this narrative
RVTY
Revvity
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Regulatory Shifts Will Pressure Diagnostics Yet Spur Measured Turnaround
Key Takeaways Regulatory shifts and market-specific declines threaten revenue growth and earnings recovery, despite innovation and expansion in high-growth segments. Heavy reliance on biopharma and diagnostics exposes Revvity to budget cuts and pricing pressures, undermining revenue stability and margin expansion.
View narrative
US$100.00
FV
7.9% undervalued
intrinsic discount
4.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
RB Global
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Digital Shifts And Decarbonization Will Erode Profit Margins
Key Takeaways Digital transformation and emerging competitors threaten RB Global's traditional auction model, pressuring fees, margins, and long-term revenue growth. Industry trends toward decarbonization and automation reduce demand for used equipment, shrinking the customer base and weakening earnings and profitability.
View narrative
US$99.69
FV
15.4% overvalued
intrinsic discount
8.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Gen Digital
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Open Source Cybersecurity Will Erode Margins Despite Subscription Recovery
Key Takeaways Free cybersecurity alternatives and enhanced device security features are reducing Gen Digital's core recurring revenue and eroding its product differentiation. Regulatory constraints and customer churn threaten personalization, product innovation, and long-term earnings growth.
View narrative
US$25.00
FV
24.5% overvalued
intrinsic discount
7.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
6 days ago
author updated this narrative
Value any company in seconds
Popular companies